Our mission is to develop best-in-class, safe and effective oral iron chelators for the treatment of diseases of iron overload.
Member count: 11-50
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | Deepwork C... | deepworkca... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 17.02.2021 | AbFero Pha... | HARWELL, England, Feb. 17, 2... | - | - | prnewswire... |
| 09.12.2020 | AbFero Pha... | Following the completion of a ... | - | - | deepworkca... |